IMMUNOTHERAPEUTIC STRATEGIES FOR CERVICAL SQUAMOUS CARCINOMA
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 13 (1) , 259-273
- https://doi.org/10.1016/s0889-8588(05)70164-7
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- DNA VACCINESAnnual Review of Immunology, 1997
- The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancerNature Medicine, 1995
- Natural history of HLA expression during tumour developmentImmunology Today, 1993
- Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cellsEuropean Journal of Immunology, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53Published by Elsevier ,1992
- HLA-A2.1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen PresentationScience, 1992
- Two types of mouse helper T-cell clone: Implications for immune regulationImmunology Today, 1987
- Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cellsNature, 1984